% | $
Quotes you view appear here for quick access.

ZIOPHARM Oncology, Inc. Message Board

  • jimfromsavannah jimfromsavannah Apr 3, 2013 5:10 PM Flag

    1 year ago today.....

    KERX closed at this same price after a gigantic collapse. Then bottomed at $1.28. Look at it now, there's hope for the patient ZIOP longs.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Actually, that is very common with the biotech stocks. Since most of these start-up companies deal with multiple drugs in their pipeline, any not-so-good news may crush the stock. However, good news on any of the drugs may lead to the recovery within a short time. The mood swings once in a while leading to catastophe, but generally it recovers after a while. XOMA, ENMD, INSM, ANTH, . .....all these stocks took beatings. KERX is a recent example. I think Affy and Ziop will recover with some good news with some of their other drugs in the pipiline. ZIOP has Indibulin (Zeo 301) which is undergoing phase 1/2 trials for breast and ovarian cancers, and in my opinion Indibulin is much better than palifosphamide.

5.91+0.43(+7.85%)Sep 28 4:00 PMEDT